Clinical Evaluation of Effects of Insulin-therapy or Liraglutide-therapy on Insulin Sensitivity in Type-2 Diabetes

Clinical Evaluation of Effects of Insulin-therapy or Liraglutide-therapy on Insulin Sensitivity in Type-2 Diabetes - Effects of Liraglutide or Insulin-therapy on Insulin Sensitivity

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015201

Enrollment

Registered

2014-09-18

Start date

2014-09-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type-2 diabetes

Interventions

Liraglutide-therapy Intensive insulin-therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Stable patients with type-2 DM who are already treated in the out-patients clinic of Jinnouchi Hospital. HbA1c>=7.0% capable of exercise-tharepy and diet-therapy

Exclusion criteria

Exclusion criteria: Type-1 DM unstable condition in CVD active inflammation severe liver disease dementia CKD>=stage-4 disability in bed cancer

Design outcomes

Primary

Measure	Time frame
Changes in Insulin sensitivity assessed by hyperinsulinemic-euglycemic clamp examination	—

Secondary

Measure	Time frame
We examine the correlated factors for the changes of insulin sensitivity.	—

Countries

Japan

Contacts

Public ContactSeigo Sugiyama

Jinnouchi Hospital Diabetes Care Center

ssugiyam@kumamoto-u.ac.jp096-363-0011

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026